Your browser doesn't support javascript.
loading
13-Weeks subchronic toxicity of isoquercitrin-γ-cyclodextrin (IQC-γCD) molecular inclusion complex in Sprague-Dawley rats.
Kapoor, Mahendra P; Moriwaki, Masamitsu; Timm, Derek; Yamagata, Hiroshi; Maruyama, Go; Nisihara, Yoshito; Nakazawa, Tomomi; Takata, Shinro; Nakamura, Daichi.
Afiliação
  • Kapoor MP; Taiyo Kagaku Co. Ltd., Nutrition Division, 1-3 Takaramachi, Yokkaichi, Mie, 510-0844, Japan. Electronic address: mkapoor@taiyokagaku.co.jp.
  • Moriwaki M; Taiyo Kagaku Co. Ltd., Nutrition Division, 1-3 Takaramachi, Yokkaichi, Mie, 510-0844, Japan.
  • Timm D; Taiyo International Inc., 5960 Golden Hills Dr., Minneapolis, MN, 55416, USA.
  • Yamagata H; Gotemba Laboratory, BoZo Research Center Inc., 1284, Kamado, Gotemba-shi, Shizuoka, 412-0039, Japan.
  • Maruyama G; Gotemba Laboratory, BoZo Research Center Inc., 1284, Kamado, Gotemba-shi, Shizuoka, 412-0039, Japan.
  • Nisihara Y; Gotemba Laboratory, BoZo Research Center Inc., 1284, Kamado, Gotemba-shi, Shizuoka, 412-0039, Japan.
  • Nakazawa T; Gotemba Laboratory, BoZo Research Center Inc., 1284, Kamado, Gotemba-shi, Shizuoka, 412-0039, Japan.
  • Takata S; Gotemba Laboratory, BoZo Research Center Inc., 1284, Kamado, Gotemba-shi, Shizuoka, 412-0039, Japan.
  • Nakamura D; Tsukuba Institute, BoZo Research Center Inc., 8 Okubo, Tsukuba-shi, Ibaraki, 300-2611, Japan.
Food Chem Toxicol ; 152: 112217, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33865935
ABSTRACT
Flavonoids such as quercetin and its glycoside Isoquercitrin and are abundantly present in the diet and have various pharmacological effects. However, limited data about its potential toxicity is available. In this study, we aim to evaluate the subchronic toxicity of the isoquercitrin-γ-cyclodextrin (IQC-γCD) molecular inclusion complex (SunActive® QCD/EN) in Sprague-Dawley (SD) rats. The IQC-γCD was administrated orally to 40 male and 40 female SD rats at dietary doses up to 5.0 % for 13 consecutive weeks. During the experiment periods, the general clinical signs, mortality, hematological, urinalysis values, biochemical, and histopathological parameters were examined. All animals survived until the scheduled necropsy, and no statistically significant or clinical sign of toxicologically relevant differences including pathology parameters, and histopathological endpoints were observed in any of the IQC-γCD treatment groups, compared with the control group. However, certain observations were noted in the male rats treated with the highest concentration (5.0 %), but these were not seen in female rats. A slight inhibition of weight gain was observed, probably linked to a fall in red blood cells, and hematocrit index in female rats. Statistically significant changes were noted in some clinical measures, such as plasma bilirubin level, alkaline phosphatase total bile acid without evidence of systemic clinical toxicity. The results support no observed adverse effect level (NOAEL) of IQC-γCD of 5.0 % in the diet for males (3338.55 mg/kg/day), and 3.0 % in the diet for females (2177.33 mg/kg/day) SD rats. Therefore, in this 13 weeks repeated-dose SD rat study there were no treatment-related adverse clinical or pathological findings for IQC-γCD of 5.0 % in the diet for males, and 3.0 % in the diet for females SD rats. The results of the present study support the safe use of IQC-γCD as a functional food, food additive, and natural ingredient.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quercetina / Gama-Ciclodextrinas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quercetina / Gama-Ciclodextrinas Idioma: En Ano de publicação: 2021 Tipo de documento: Article